These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 25100890)

  • 21. Standardization of micro-enzyme-linked immunosorbent assay (ELISA) and Western blot for detection of Trypanosoma cruzi antibodies using extracts from Mexican strains as antigens.
    Sánchez B; Monteón V; Reyes PA; Espinoza B
    Arch Med Res; 2001; 32(5):382-8. PubMed ID: 11578752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of conventional serology and PCR methods for the routine diagnosis of Trypanosoma cruzi infection.
    Gilber SR; Alban SM; Gobor L; Bescrovaine Jde O; Myiazaki MI; Thomaz-Soccol V
    Rev Soc Bras Med Trop; 2013; 46(3):310-5. PubMed ID: 23856879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enzyme-linked immunosorbent assay and polymerase chain reaction performance using Mexican and Guatemalan discrete typing unit I strains of Trypanosoma cruzi.
    Ballinas-Verdugo M; Reyes PA; Mejia-Dominguez A; López R; Matta V; Monteón VM
    Vector Borne Zoonotic Dis; 2011 Dec; 11(12):1569-75. PubMed ID: 21867413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An improved serodiagnostic test for Chagas' disease employing a mixture of Trypanosoma cruzi recombinant antigens.
    Umezawa ES; Bastos SF; Coura JR; Levin MJ; Gonzalez A; Rangel-Aldao R; Zingales B; Luquetti AO; da Silveira JF
    Transfusion; 2003 Jan; 43(1):91-7. PubMed ID: 12519436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of in-house ELISA using Trypanosoma cruzi lysate and recombinant antigens for diagnosis of Chagas disease and discrimination of its clinical forms.
    Longhi SA; Brandariz SB; Lafon SO; Niborski LL; Luquetti AO; Schijman AG; Levin MJ; Gómez KA
    Am J Trop Med Hyg; 2012 Aug; 87(2):267-71. PubMed ID: 22855757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimization and evaluation of the ARCHITECT Chagas assay and in-house ELISA for Chagas disease in clinical settings in Japan.
    Imai K; Murakami T; Misawa K; Fujikura Y; Kawana A; Tarumoto N; Maesaki S; Maeda T
    Parasitol Int; 2021 Feb; 80():102221. PubMed ID: 33137505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymerase chain reaction amplification of Trypanosoma cruzi kinetoplast minicircle DNA isolated from whole blood lysates: diagnosis of chronic Chagas' disease.
    Avila HA; Sigman DS; Cohen LM; Millikan RC; Simpson L
    Mol Biochem Parasitol; 1991 Oct; 48(2):211-21. PubMed ID: 1662334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chagas' disease diagnosis: comparative analysis of recombinant ELISA with conventional ELISA and the haemagglutination test.
    Gadelha AA; Verçosa AF; Lorena VM; Nakazawa M; Carvalho AB; Souza WV; Ferreira AG; Silva ED; Krieger MA; Goldenberg S; Gomes YM
    Vox Sang; 2003 Oct; 85(3):165-70. PubMed ID: 14516446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-house ELISA method to analyze anti-Trypanosoma cruzi IgG reactivity for differential diagnosis and evaluation of Chagas disease morbidity.
    Santos Lda S; Torres RM; Machado-de-Assis GF; Bahia MT; Martins HR; Teixeira-Carvalho A; Coelho-Dos-Reis JG; Albajar-Viñas P; Martins-Filho OA; Lana Md
    Rev Soc Bras Med Trop; 2012 Feb; 45(1):35-44. PubMed ID: 22370826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enzyme-linked immunosorbent assay for serological diagnosis of Chagas' disease employing a Trypanosoma cruzi recombinant antigen that consists of four different peptides.
    Ferreira AW; Belem ZR; Lemos EA; Reed SG; Campos-Neto A
    J Clin Microbiol; 2001 Dec; 39(12):4390-5. PubMed ID: 11724850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid diagnostic tests duo as alternative to conventional serological assays for conclusive Chagas disease diagnosis.
    Egüez KE; Alonso-Padilla J; Terán C; Chipana Z; García W; Torrico F; Gascon J; Lozano-Beltran DF; Pinazo MJ
    PLoS Negl Trop Dis; 2017 Apr; 11(4):e0005501. PubMed ID: 28369081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of UMELISA CHAGAS™ with the incorporation of new monomeric and chimeric peptides representative of different regions of Trypanosoma cruzi.
    Hernández I; Hernández M; González J; Gómez I; Zulueta O; Ramos G; Ortega D; Bequer DC; Martínez GE; Delahanty A
    Biomedica; 2021 May; 41(Supl. 1):113-120. PubMed ID: 34111344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amplification of a Trypanosoma cruzi DNA sequence from inflammatory lesions in human chagasic cardiomyopathy.
    Jones EM; Colley DG; Tostes S; Lopes ER; Vnencak-Jones CL; McCurley TL
    Am J Trop Med Hyg; 1993 Mar; 48(3):348-57. PubMed ID: 8470772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. International study to evaluate PCR methods for detection of Trypanosoma cruzi DNA in blood samples from Chagas disease patients.
    Schijman AG; Bisio M; Orellana L; Sued M; Duffy T; Mejia Jaramillo AM; Cura C; Auter F; Veron V; Qvarnstrom Y; Deborggraeve S; Hijar G; Zulantay I; Lucero RH; Velazquez E; Tellez T; Sanchez Leon Z; Galvão L; Nolder D; Monje Rumi M; Levi JE; Ramirez JD; Zorrilla P; Flores M; Jercic MI; Crisante G; Añez N; De Castro AM; Gonzalez CI; Acosta Viana K; Yachelini P; Torrico F; Robello C; Diosque P; Triana Chavez O; Aznar C; Russomando G; Büscher P; Assal A; Guhl F; Sosa Estani S; DaSilva A; Britto C; Luquetti A; Ladzins J
    PLoS Negl Trop Dis; 2011 Jan; 5(1):e931. PubMed ID: 21264349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic Chagas Disease Diagnosis: A Comparative Performance of Commercial Enzyme Immunoassay Tests.
    Santos FL; de Souza WV; Barros Mda S; Nakazawa M; Krieger MA; Gomes Yde M
    Am J Trop Med Hyg; 2016 May; 94(5):1034-9. PubMed ID: 26976886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study of cases of leishmaniasis in the Province of Salta: evidences of mixed infection with Trypanosoma cruzi and Leishmania spp].
    Chiaramonte MG; Zwirner NW; Caropresi SL; Heredia V; Taranto NJ; Malchiodi EL
    Medicina (B Aires); 1996; 56(3):259-68. PubMed ID: 9035482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies.
    Sguassero Y; Cuesta CB; Roberts KN; Hicks E; Comandé D; Ciapponi A; Sosa-Estani S
    PLoS One; 2015; 10(10):e0139363. PubMed ID: 26436678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of Trypanosoma cruzi in blood specimens of chronic chagasic patients by polymerase chain reaction amplification of kinetoplast minicircle DNA: comparison with serology and xenodiagnosis.
    Avila HA; Pereira JB; Thiemann O; De Paiva E; DeGrave W; Morel CM; Simpson L
    J Clin Microbiol; 1993 Sep; 31(9):2421-6. PubMed ID: 8408566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody levels correlate with detection of Trypanosoma cruzi DNA by sensitive polymerase chain reaction assays in seropositive blood donors and possible resolution of infection over time.
    Sabino EC; Lee TH; Montalvo L; Nguyen ML; Leiby DA; Carrick DM; Otani MM; Vinelli E; Wright D; Stramer SL; Busch M;
    Transfusion; 2013 Jun; 53(6):1257-65. PubMed ID: 23002996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic Performance of Peripheral Blood Biomarkers in Identifying Seropositive Individuals at Risk of Developing Clinically Symptomatic Chagas Cardiomyopathy.
    Choudhuri S; Bhavnani SK; Zhang W; Botelli V; Barrientos N; Iñiguez F; Zago MP; Garg NJ
    Microbiol Spectr; 2021 Sep; 9(1):e0036421. PubMed ID: 34479416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.